Anavex Life Sciences Corp (AVXL)

[wildcard235]

"We can confirm that ANAVEX... is planning a large scale placebo controlled phase 3 trial to start (at latest) by mid-2017." This statement is from the middle of the following email to me. I will not qualify unless the terms change because I have MCI, not AD, and because I had encephalitis a few years ago.


AD Clinical Trials <[e-mail]>

Thank you for interest in the Alzheimer’s clinical trials at Caulfield Hospital.

We are thrilled by the media coverage highlighting the fight against Alzheimer’s disease.

To be considered as a participant in an Alzheimer’s disease clinical trial here at Caulfield Hospital the following key criteria needs be assessed:

· A confirmed diagnoses with Alzheimer’s disease (and has no other subtype of dementia, such as frontotemporal/vascular dementia)

· Our trials are for people with mild to moderate Alzheimer disease as defined by a minimum score of 12 or above out 30 on the Mini Mental State Examination cognitive test

· No history of cancer within last 5 years

· No other significant illness such as uncontrolled type 1 diabetes, uncontrolled hypertension, uncontrolled cholesterol

· No other neurological diagnoses such as Parkinson’s disease, uncontrolled depression, major depressive disorder, bi-polar disorders


Please note: There is no current trial recruiting for the drug Anavex 2-73 or solenazumab.

We can confirm that ANAVEX (the biotech company that owns the molecule) is planning a large scale placebo controlled phase 3 trial to start (at latest) by mid-2017. For further updates regarding this trial please visit alfredhealth.org.au or http://www.anavex.com/pipeline/anavex-2-73/


If you meet the above key criteria’s and you would like to know more about the current clinical trials in your home state contact the following clinical trial centres:

Victorian residents:

If you are interested in trials (other than the ANAVEX2-73 study) please send us a recent copy of:

· Health summary from the GP, which generally includes current medication including past and current medication conditions,

· The results of an MRI brain or CT brain that was undertaken for diagnosis

· The current Mini Mental State Examination (MMSE) score. The MMSE is a score out 30 questions. (if available).

Please e-mail this information to [e-mail] and we will do our very best to get back to you but it may take approximately 1-2 months for this to occur.

We greatly appreciate your patience while we sift through everyone’s enquiry.


Please note: For each state please email the following information with your enquiry

· Health summary from the GP, which generally includes current medication including past and current medication conditions,

· The results of an MRI brain or CT brain that was undertaken for diagnosis

· The current Mini Mental State Examination (MMSE) score. The MMSE is a score out 30 questions. (if available).

Western Australia:

· Perth:

· Professor Peter K Panegyres- Neurodegenerative Disorders Research- West Perth

· Please email [e-mail]

New South Wales:

· Sydney

· Prof Bruce Brew St Vincent’s Hospital

· Please email research coordinator: [e-mail]

· Central Coast New South Wales –

· Dr Jonathan Sturm- Central Coast Neurosciences Research - Kanwal

· Please email research coordinator [e-mail]

Queensland

· The University of Queensland- school of medicine – Brisbane

· Please email [e-mail]

· Dr Phillip Morris – Gold Coast - [e-mail]

South Australia

· Dr Cathy Short- Queen Elisabeth Hospital

· Please email [e-mail]

Yours Sincerely,

Aged Psychiatry Clinical Trials Team.